Page last updated: 2024-11-02

pheniramine and Down Syndrome

pheniramine has been researched along with Down Syndrome in 1 studies

Pheniramine: One of the HISTAMINE H1 ANTAGONISTS with little sedative action. It is used in treatment of hay fever, rhinitis, allergic dermatoses, and pruritus.

Down Syndrome: A chromosome disorder associated either with an extra chromosome 21 or an effective trisomy for chromosome 21. Clinical manifestations include hypotonia, short stature, brachycephaly, upslanting palpebral fissures, epicanthus, Brushfield spots on the iris, protruding tongue, small ears, short, broad hands, fifth finger clinodactyly, Simian crease, and moderate to severe INTELLECTUAL DISABILITY. Cardiac and gastrointestinal malformations, a marked increase in the incidence of LEUKEMIA, and the early onset of ALZHEIMER DISEASE are also associated with this condition. Pathologic features include the development of NEUROFIBRILLARY TANGLES in neurons and the deposition of AMYLOID BETA-PROTEIN, similar to the pathology of ALZHEIMER DISEASE. (Menkes, Textbook of Child Neurology, 5th ed, p213)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Seidl, R1
Hauser, E1
Bernert, G1
Marx, M1
Freilinger, M1
Lubec, G1

Trials

1 trial available for pheniramine and Down Syndrome

ArticleYear
Auditory evoked potentials in young patients with Down syndrome. Event-related potentials (P3) and histaminergic system.
    Brain research. Cognitive brain research, 1997, Volume: 5, Issue:4

    Topics: Adolescent; Adult; Child; Down Syndrome; Evoked Potentials, Auditory; Evoked Potentials, Auditory, B

1997